Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,831,215
+$7,821,093 QoQ
Shares Held
158,843
-8.4% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#111
of 596 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Polar Capital Holdings Plc holds $156,441,144 across 6 Diagnostics & Research names. GH ranks #4 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
85,677 | $42,955,020 | |
| 2 | RDNT |
RadNet, Inc.
|
623,029 | $38,422,198 | |
| 3 | A |
Agilent Technologies, Inc.
|
215,707 | $28,652,360 | |
| 4 | GH |
Guardant Health, Inc.
This page
|
158,843 | $23,831,215 | |
| 5 | ICLR |
Icon PLC
|
116,939 | $20,313,473 | |
| 6 | NTRA |
Natera, Inc.
|
8,351 | $2,266,878 |
All Filings in GH
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,831,215 | 158,843 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $16,010,122 | 173,326 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,085,517 | 157,485 | Shares | Defined | 2026-02-17 | |
| 2023-06-30 | $358,358 | 10,010 | Shares | Defined | 2023-12-13 | |
| 2022-06-30 | $1,480,074 | 36,690 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,451,129 | 67,197 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $13,048,409 | 130,458 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $71,056,809 | 568,409 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $81,908,769 | 659,544 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $106,010,540 | 694,468 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||